Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Ji, Xuemei ^a   Bossé, Yohan ^b,c   Landi, Maria Teresa ^d   Gui, Jiang ^a   Xiao, Xiangjun ^a   Qian, David ^a   Joubert, Philippe ^c   Lamontagne, Maxime ^c   Li, Yafang ^a   Gorlov, Ivan ^a   de Biasi, Mariella ^e,f   Han, Younghun ^a   Gorlova, Olga ^a   Hung, Rayjean J ^g   Wu, Xifeng ^h   McKay, James ⁱ   Zong, Xuchen ^g   Carreras Torres, Robert ⁱ   Christiani, David C ^j,k   Caporaso, Neil ^d   Johansson, Mattias ⁱ   Liu, Geoffrey ^g   Bojesen, Stig E ^l,m   Le Marchand, Loic ⁿ   Albanes, Demetrios ^d   Bickeböller, Heike ^o   Aldrich, Melinda C ^p   Bush, William S ^p,q   Tardon, Adonina ^r,s   Rennert, Gad ^t,u   Chen, Chu ^v   Teare, M Dawn ^w   Field, John K ^x   Kiemeney, Lambertus A ^y   Lazarus, Philip ^z   Haugen, Aage ^aa   Lam, Stephen ^ab   Schabath, Matthew B ^ac   Andrew, Angeline S ^a   Shen, Hongbing ^ad   Hong, Yun Chul ^ae   Yuan, Jian Min ^af   Bertazzi, Pier A ^ag,ah   Pesatori, Angela C ^ag,ah   Ye, Yuanqing ^h   Diao, Nancy ^j   Su, Li ^j   Zhang, Ruyang ^j,ad   Brhane, Yonathan ^g   Leighl, Natasha ^ai   Johansen, Jakob S ^l   Mellemgaard, Anders ^l   Saliba, Walid ^t,u   Haiman, Christopher ^aj   Wilkens, Lynne ⁿ   Fernandez Somoano, Ana ^r,s   Fernandez Tardon, Guillermo ^r,s   van der Heijden, Erik H F M ^y   Kim, Jin Hee ^ak   Dai, Juncheng ^ad   Hu, Zhibin ^ad   Davies, Michael P A ^x   Marcus, Michael W ^x   Brunnström, Hans ^al   Manjer, Jonas ^al   Melander, Olle ^al   Muller, David C ^am   Overvad, Kim ^al   Trichopoulou, Antonia ^an   Tumino, Rosario ^ao   Doherty, Jennifer ^a,v   Goodman, Gary E ^v,ap   Cox, Angela ^aq   Taylor, Fiona ^aq   Woll, Penella ^aq   Brüske, Irene ^ar   Manz, Judith ^ar   Muley, Thomas ^as,at   Risch, Angela ^au   Rosenberger, Albert ^o   Grankvist, Kjell ^av   Johansson, Mikael ^av   Shepherd, Frances ^ai   Tsao, Ming Sound ^ai   Arnold, Susanne M ^aw   Haura, Eric B ^ac   Bolca, Ciprian ^ax   Holcatova, Ivana ^ay   Janout, Vladimir ^ay   Kontic, Milica ^az   Lissowska, Jolanta ^ba   Mukeria, Anush ^bb   Ognjanovic, Simona ^bc   Orlowski, Tadeusz M ^bd   Scelo, Ghislaine ⁱ   Swiatkowska, Beata ^be   Zaridze, David ^bb   Bakke, Per ^bf   Skaug, Vidar ^aa   Zienolddiny, Shanbeh ^aa   Duell, Eric J ^bg   Butler, Lesley M ^af   Koh, Woon Puay ^bh,bi   Gao, Yu Tang ^bj   Houlston, Richard ^bk   McLaughlin, John ^bl   Stevens, Victoria ^bm   Nickle, David C ^bn   Obeidat, Ma’en ^bo   Timens, Wim ^bp   Zhu, Bin ^d   Song, Lei ^d   Artigas, María Soler ^bq,br   Tobin, Martin D ^bq,br   Wain, Louise V ^bq,br   Gu, Fangyi ^d   Byun, Jinyoung ^a   Kamal, Ahsan ^a   Zhu, Dakai ^a   Tyndale, Rachel F ^bs,bt   Wei, Wei Qi ^p   Chanock, Stephen ^d   Brennan, Paul ⁱ   Amos, Christopher I ^a,bu   more..

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MOUNT SINAI HOSPITAL   (Canada)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^m UNIVERSITY OF COPENHAGEN   (Denmark)

ⁿ UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^o UNIVERSITY OF GÖTTINGEN   (Germany)

^p VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^q CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF OVIEDO   (Spain)

^s CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^t CLALIT HEALTH SERVICES   (Israel)

^u TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^v USA   (United States)

^w UNIVERSITY OF SHEFFIELD   (United Kingdom)

^x UNIVERSITY OF LIVERPOOL   (United Kingdom)

^y RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^z WASHINGTON STATE UNIVERSITY   (United States)

^aa NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^ab BRITISH COLUMBIA CANCER AGENCY   (Canada)

^ac H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^ad NANJING MEDICAL UNIVERSITY   (China)

^ae Seoul National University College of Medicine   (South Korea)

^af UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^ag FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^ah UNIVERSITY OF MILAN   (Italy)

^ai PRINCESS MARGARET HOSPITAL   (Canada)

^aj UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ak Sejong University   (South Korea)

^al LUND UNIVERSITY   (Sweden)

^am IMPERIAL COLLEGE LONDON   (United Kingdom)

^an HELLENIC HEALTH FOUNDATION   (Greece)

^ao CIVILE M P AREZZO HOSPITAL   (Italy)

^ap Swedish Medical Group   (United States)

^aq UNIVERSITY OF SHEFFIELD   (United Kingdom)

^ar INSTITUTE OF EPIDEMIOLOGY   (Germany)

^as UNIVERSITY OF HEIDELBERG   (Germany)

^at Heidelberg Translational Lung Research Center (TLRC)   (Germany)

^au UNIVERSITY OF SALZBURG   (Austria)

^av UMEÅ UNIVERSITY   (Sweden)

^aw UNIVERSITY OF KENTUCKY   (United States)

^ax Marius Nasta Institute of Pneumophthisiology   (Romania)

^ay CHARLES UNIVERSITY   (Czech Republic)

^az UNIVERSITY OF BELGRADE   (Serbia)

^ba INSTITUTE OF ONCOLOGY   (Poland)

^bb N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^bc International Organization for Cancer Prevention and Research (IOCPR)   (Serbia)

^bd NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^be NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^bf UNIVERSITY OF BERGEN   (Norway)

^bg CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^bh DUKE NUS MEDICAL SCHOOL   (Singapore)

^bi NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^bj SHANGHAI CANCER INSTITUTE   (China)

^bk INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^bl PUBLIC HEALTH ONTARIO   (Canada)

^bm AMERICAN CANCER SOCIETY   (United States)

^bn MERCK RESEARCH LABORATORIES   (United States)

^bo UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^bp UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^bq UNIVERSITY OF LEICESTER   (United Kingdom)

^br GLENFIELD HOSPITAL   (United Kingdom)

^bs UNIVERSITY OF TORONTO   (Canada)

^bt CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^bu BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CHROMOSOME; ETIOLOGY; GENETIC ANALYSIS; IDENTIFICATION METHOD; LIGAND; PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CHROMOSOME 15Q; CHROMOSOME 15Q25.1; COHORT ANALYSIS; CONTROLLED STUDY; EXPRESSION QUANTITATIVE TRAIT LOCUS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INFANT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEWBORN; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; CHROMOSOME 15; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED; PRESCHOOL CHILD; QUANTITATIVE TRAIT LOCUS; REPRODUCIBILITY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 15; COHORT STUDIES; FEMALE; GENE ONTOLOGY; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 85051632965     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-05074-y     Document Type: Article

References (65)

1. Siegel, R., Ward, E., Brawley, O. & Jemal, A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61, 212–236 (2011)
2. Amos, C. I. et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40, 616–622 (2008)
3. Hung, R. J. et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633–637 (2008)
4. Thorgeirsson, T. E. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638–642 (2008)
5. Liu, J. Z. et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 42, 436–440 (2010)
6. Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42, 441–447 (2010)
7. Walsh, K. M. et al. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol. Biomarkers Prev. 22, 251–260 (2013)
8. Chen, L. S. et al. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry—a meta-analysis of chromosome 15q25. Genet. Epidemiol. 36, 340–351 (2012)
9. Paliwal, A. et al. Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res. 70, 2779–2788 (2010)
10. Nguyen, J. D. et al. Susceptibility loci for lung cancer are associated with mRNA levels of nearby genes in the lung. Carcinogenesis 35, 2653–2659 (2014)
11. Ji, X. et al. The role of haplotype in 15q25.1 locus in lung cancer risk: results of scanning chromosome 15. Carcinogenesis 36, 1275–1283 (2015)
12. Fellay, J. et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 5, e1000791 (2009)
13. Zhang, K., Cui, S., Chang, S., Zhang, L. & Wang, J. i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Res. 38, W90–W95 (2010)
14. Kwon, J. S., Kim, J., Nam, D. & Kim, S. Performance comparison of two gene set analysis methods for genome-wide association study results: GSA-SNP vs i-GSEA4GWAS. Genomics Inform. 10, 5 (2012)
15. Nam, D., Kim, J., Kim, SY. & Kim, S. GSA-SNP: a general approach for gene set analysis of polymorphisms. Nucleic Acids Res. 38, 6 (2010)
16. George, A. A. et al. Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variant. J. Biol. Chem. 287, 25151–25162 (2012)
17. Amos, C. I. et al. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J. Natl. Cancer Inst. 102, 1199–1205 (2010)
18. Wu, C. et al. Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res. 69, 5065–5072 (2009)
19. Koster, R. et al. Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors. Hum. Mol. Genet. 23, 6061–6068 (2014)
20. Truong, T. et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J. Natl. Cancer Inst. 102, 959–971 (2010)
21. Jaworowska, E. et al. Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PLoS ONE 6, e25057 (2011)
22. Makinen, V. P. et al. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet. 10, e1004502 (2014)
23. Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013)
24. Bunyavanich, S. et al. Integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism analysis identifies novel pathway in allergic rhinitis. BMC Med. Genomics 7, 48 (2014)
25. Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196 (2015)
26. Adkins, D. E. et al. SNP-based analysis of neuroactive ligand–receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study. Schizophr. Res. 135, 200–201 (2012)
27. Ren, C. et al. CRISPR/Cas9-mediated efficient targeted mutagenesis in Chardonnay (Vitis vinifera L.). Sci. Rep. 6, 32289 (2016)
28. Mundt, E. & Bates, M. D. Genetics of Hirschsprung disease and anorectal malformations. Semin. Pediatr. Surg. 19, 107–117 (2010)
29. Puri, P. & Shinkai, T. Pathogenesis of Hirschsprung’s disease and its variants: recent progress. Semin. Pediatr. Surg. 13, 18–24 (2004)
30. Chen, W. J. et al. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma. Pathol. Res. Pract. 213, 364–372 (2017)
31. Wu, X., Zang, W., Cui, S. & Wang, M. Bioinformatics analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. Eur. Rev. Med. Pharmacol. Sci. 16, 1582–1587 (2012)
32. Lassi, G. et al. The CHRNA5-A3-B4 gene cluster and smoking: from discovery to therapeutics. Trends Neurosci. 39, 851–861 (2016)
33. Li, M. D. et al. Association and interaction analyses of GABBR1 and GABBR2 with nicotine dependence in European- and African-American populations. PLoS One 4, e7055 (2009)
34. Begum, F. et al. Hemizygous deletion on chromosome 3p26.1 is associated with heavy smoking among African American subjects in the COPD gene study. PLoS ONE 11, e0164134 (2016)
35. Vink, J. M. et al. Genome-wide association study of smoking initiation and current smoking. Am. J. Hum. Genet. 84, 367–379 (2009)
36. Saccone, N. L. et al. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am. J. Med. Genet. B, Neuropsychiatr. Genet. 150B, 453–466 (2009)
37. Biernacka, J. M. et al. Genome-wide gene-set analysis for identification of pathways associated with alcohol dependence. Int. J. Neuropsychopharmacol. 16, 271–278 (2013)
38. Kong, Y. et al. High throughput sequencing identifies microRNAs mediating alpha-synuclein toxicity by targeting neuroactive-ligand receptor interaction pathway in early stage of Drosophila Parkinson’s disease model. PLoS ONE 10, e0137432 (2015)
39. Putnam, D. K., Sun, J. & Zhao, Z. Exploring schizophrenia drug–gene interactions through molecular network and pathway modeling. AMIA Annu. Symp. Proc. 2011, 1127–1133 (2011)
40. Wen, Y., Alshikho, M. J. & Herbert, M. R. Pathway network analyses for autism reveal multisystem involvement, major overlaps with other diseases and convergence upon MAPK and calcium signaling. PLoS One 11, e0153329 (2016)
41. Lee, J. M., Davis, F. M., Roberts-Thomson, S. J. & Monteith, G. R. Ion channels and transporters in cancer. 4. Remodeling of Ca(2+) signaling in tumorigenesis: role of Ca(2+) transport. Am. J. Physiol. Cell Physiol. 301, C969–C976 (2011)
42. Prevarskaya, N., Skryma, R. & Shuba, Y. Targeting Ca(2)(+) transport in cancer: close reality or long perspective? Expert Opin. Ther. Targets 17, 225–241 (2013)
43. Deliot, N. & Constantin, B. Plasma membrane calcium channels in cancer: alterations and consequences for cell proliferation and migration. Biochim. Biophys. Acta 1848, 2512–2522 (2015)
44. Kim, Y. S., Kim, Y., Choi, J. W., Oh, H. E. & Lee, J. H. Genetic variants and risk of prostate cancer using pathway analysis of a genome-wide association study. Neoplasma 63, 629–634 (2016)
45. Tomoshige, K. et al. Germline mutations causing familial lung cancer. J. Hum. Genet. 60, 597–603 (2015)
46. Frullanti, E. et al. Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue. Int. J. Cancer 131, E643–E648 (2012)
47. Lee, J., Katzenmaier, E. M., Kopitz, J. & Gebert, J. Reconstitution of TGFBR2 in HCT116 colorectal cancer cells causes increased LFNG expression and enhanced N-acetyl-d-glucosamine incorporation into Notch1. Cell Signal. 28, 1105–1113 (2016)
48. Cheung, A. K. et al. PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma. Oncotarget 6, 13434–13447 (2015)
49. Englinger, B. et al. Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression. Oncotarget. 7, 50161–50179 (2016)
50. Cui, Y. et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One 3, e2990 (2008)
51. Anglim, P. P. et al. Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer. Mol. Cancer 7, 62 (2008)
52. Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L. & Comoglio, P. M. Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis. Cancer Res. 71, 3132–3141 (2011)
53. Yamaguchi, T. et al. NKX2-1/TITF1/TTF-1-induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell. 21, 348–361 (2012)
54. Landi, M. T. et al. Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health 8, 203 (2008)
55. Wang, Y. et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat. Genet. 46, 736–741 (2014)
56. McKay, J. et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat. Genet. 49, 1126–1132 (2017)
57. Bosse, Y. et al. Molecular signature of smoking in human lung tissues. Cancer Res. 72, 3753–3763 (2012)
58. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009)
59. Ogata, H. et al. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27, 29–34 (1999)
60. Gene Ontology Consortium. The Gene Ontology (GO) project in 2006. Nucleic Acids Res. 34, D322–D326 (2006)
61. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. U.S.A. 102, 15545–15550 (2005)
62. Wang, K., Li, M. & Bucan, M. Pathway-based approaches for analysis of genomewide association studies. Am. J. Hum. Genet. 81, 1278–1283 (2007)
63. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003)
64. Heber, S. & Sick, B. Quality assessment of Affymetrix GeneChip data. OMICS 10, 358–368 (2006)
65. da Huang, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009)